16 June 2022 - Hugel said Thursday that it has obtained product approval from Health Canada for its botulinum toxin formulation, Letybo, which treats forehead wrinkles.
The company had completed an on-site inspection of the Geodu plant, Hugel's botulinum toxin production base, to obtain a Canadian product license in November 2019 and applied for a product license on 1 July 2021.